GET /api/v0.1/hansard/entries/1339681/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1339681,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1339681/?format=api",
    "text_counter": 922,
    "type": "speech",
    "speaker_name": "Endebess, UDA",
    "speaker_title": "Hon. (Dr) Robert Pukose",
    "speaker": null,
    "content": "This Bill provides for the regulation of medicines. It, therefore, penalises the sale of adulterated and substandard medicine, and medicine which has not been registered by the Kenya Drugs Authority. It requires compliance with standards of manufacturing, labelling, packaging, sale or advertisement. The Bill penalises the manufacture, sale, preparation and storage of medicine, including herbal medicine, contrary to prescribed standards. It sets out the factors that warrant the issuance of a product license and provides for the establishment and management of a medicines register. It also provides the procedure for registration of medicines. Part V of the Bill, which comprises clauses 7 to 46 provides for regulation of scheduled substances. Under this Part, the Kenya Drugs Authority (KDA) is expected to prepare and submit a list of scheduled substances to the Cabinet Secretary that will only be sold by authorised sellers who are specially licensed to do so. The Bill, therefore, criminalises the possession of scheduled substances by unlicensed persons. The Bill further makes provision for licensing of dealers of scheduled substances, labelling of containers that will be used to The electronic version of the Official Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Hansard Editor."
}